Convalescent Plasma Therapy

Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events than those getting standard care.

Convalescent plasma therapy, widely used in hospitals for treating moderate and serious coronavirus patients, has been dropped from the centre's list of recommended lines of treatment for COVID-19.

India's top medical research body -- Indian Council of Medical Research (ICMR) on Wednesday said that indiscriminate use of Convalescent Plasma Therapy (CPT) should be avoided as it does not reduce mortality in COVID-19 patients.

Convalescent plasma therapy, which uses the blood of recovered COVID-19 patients as a potential treatment, has shown limited effect in reducing the progression to severe disease or death in a trial conducted in India, scientists say.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

Convalescent plasma therapy has not been recommended by the Ministry of Health as a mainstay of COVID-19 therapy and there is no proposal under consideration to set up plasma banks, Rajya Sabha was informed.

Health Minister Satyender Jain, who recovered from COVID-19 in June a week after he was given convalescent plasma therapy, CPT, said the Delhi government will continue using it as a line of treatment for severe symptoms a day after a study by the India Council of Medical Research (ICMR) stated that giving plasma had negligible effect on reducing de...

The Convalescent Plasma (CP) therapy didn't help in reducing death due to the coronavirus, the India Council of Medical Research (ICMR) revealed in a study.

What Delhi did yesterday, America does today, said Chief Minister Arvind Kejriwal on Monday as his government claimed that the US adopted the model of convalescent plasma therapy for treatment of critically-ill coronavirus patients, taking a cue from the "Delhi Model" of battling COVID-19.

COVID-19 warrior Dr Abhijit Sarma is back on duty after battling the coronavirus that he contracted while on duty on July 19. The Guwahati Medical College Hospital superintendent was given convalescent plasma soon after he was infected and he believes it worked.

Convalescent plasma therapy did not show benefit in reducing mortality risk among COVID-19 patients, according to an interim analysis of a randomised controlled trial done at AIIMS in Delhi to assess the efficacy of this mode of treatment.

Delhi's health minister Satyendar Jain, who had COVID-19 and was administered Convalescent Plasma Therapy, or CPT, after he developed complications, resumed work today, Delhi Chief Minister Arvind Kejriwal said in a tweet.

An incentive of Rs 5,000 will be given as a "gesture of gratitude" to those coronavirus survivors who donate their plasma, the Karnataka government has said, adding that system is meant to encourage survivors to help save lives of those still battling COVID-19.

Maharashtra Chief Minister Uddhav Thackeray today launched the world's largest plasma therapy trials for COVID-19 - Project Platina - aimed at creating robust data for treating the disease for which no specific line of treatment exists. His son, minister Aaditya Thackeray said the project will also help the country's worst-hit state create infrastr...

Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events than those getting standard care.

Convalescent plasma therapy, widely used in hospitals for treating moderate and serious coronavirus patients, has been dropped from the centre's list of recommended lines of treatment for COVID-19.

India's top medical research body -- Indian Council of Medical Research (ICMR) on Wednesday said that indiscriminate use of Convalescent Plasma Therapy (CPT) should be avoided as it does not reduce mortality in COVID-19 patients.

Convalescent plasma therapy, which uses the blood of recovered COVID-19 patients as a potential treatment, has shown limited effect in reducing the progression to severe disease or death in a trial conducted in India, scientists say.

The Aam Aadmi Party-led Delhi government has opposed the possible removal of convalescent plasma therapy (CPT) from the national guideline on treatment of coronavirus. It has urged the central government to continue its use as a COVID-19 treatment for severely ill coronavirus patients.

Convalescent plasma therapy may be removed from the national guideline on treatment of coronavirus, chief of India's top medical research body ICMR Dr Balram Bhargava said at a Health Ministry briefing today.

Convalescent plasma therapy has not been recommended by the Ministry of Health as a mainstay of COVID-19 therapy and there is no proposal under consideration to set up plasma banks, Rajya Sabha was informed.

Health Minister Satyender Jain, who recovered from COVID-19 in June a week after he was given convalescent plasma therapy, CPT, said the Delhi government will continue using it as a line of treatment for severe symptoms a day after a study by the India Council of Medical Research (ICMR) stated that giving plasma had negligible effect on reducing de...

The Convalescent Plasma (CP) therapy didn't help in reducing death due to the coronavirus, the India Council of Medical Research (ICMR) revealed in a study.

What Delhi did yesterday, America does today, said Chief Minister Arvind Kejriwal on Monday as his government claimed that the US adopted the model of convalescent plasma therapy for treatment of critically-ill coronavirus patients, taking a cue from the "Delhi Model" of battling COVID-19.

COVID-19 warrior Dr Abhijit Sarma is back on duty after battling the coronavirus that he contracted while on duty on July 19. The Guwahati Medical College Hospital superintendent was given convalescent plasma soon after he was infected and he believes it worked.

Convalescent plasma therapy did not show benefit in reducing mortality risk among COVID-19 patients, according to an interim analysis of a randomised controlled trial done at AIIMS in Delhi to assess the efficacy of this mode of treatment.

Delhi's health minister Satyendar Jain, who had COVID-19 and was administered Convalescent Plasma Therapy, or CPT, after he developed complications, resumed work today, Delhi Chief Minister Arvind Kejriwal said in a tweet.

An incentive of Rs 5,000 will be given as a "gesture of gratitude" to those coronavirus survivors who donate their plasma, the Karnataka government has said, adding that system is meant to encourage survivors to help save lives of those still battling COVID-19.

Maharashtra Chief Minister Uddhav Thackeray today launched the world's largest plasma therapy trials for COVID-19 - Project Platina - aimed at creating robust data for treating the disease for which no specific line of treatment exists. His son, minister Aaditya Thackeray said the project will also help the country's worst-hit state create infrastr...